Advanced Health Intelligence Ltd
AHI · NASDAQ
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.06 | 0.06 | -0.05 | -0.06 |
| FCF Yield | -28.37% | -19.59% | -53.99% | -4.08% |
| EV / EBITDA | -6.10 | -3.25 | -0.70 | -7.11 |
| Quality | ||||
| ROIC | -115.33% | -287.87% | -192.78% | -272.99% |
| Gross Margin | 0.00% | -713.51% | -4,240.21% | -1,516.31% |
| Cash Conversion Ratio | 1.14 | 0.57 | 0.49 | 0.29 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.78% | 2.30% | 3.23% | 58.61% |
| Free Cash Flow Growth | 36.13% | 25.24% | -141.06% | -49.50% |
| Safety | ||||
| Net Debt / EBITDA | -0.71 | 0.03 | 0.25 | -0.01 |
| Interest Coverage | -10.76 | -26.39 | -115.08 | -49.38 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -5,201.78 | -18.72 | 64.69 | 539.89 |